Alvine Pharmaceuticals' Debt Round

Alvine Pharmaceuticals raised a round of funding on October 21, 2011.

Alvine Pharmaceuticals is a clinical-stage, specialty biopharmaceutical company focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine…

Articles about Alvine Pharmaceuticals' Debt Round: